'Metaphyseal dysplasia without hypotrichosis' can present with late-onset extraskeletal manifestations.


Journal

Journal of medical genetics
ISSN: 1468-6244
Titre abrégé: J Med Genet
Pays: England
ID NLM: 2985087R

Informations de publication

Date de publication:
01 2020
Historique:
received: 05 03 2019
revised: 14 06 2019
accepted: 22 06 2019
pubmed: 16 8 2019
medline: 11 6 2020
entrez: 16 8 2019
Statut: ppublish

Résumé

Metaphyseal dysplasia without hypotrichosis (MDWH) is a rare form of chondrodysplasia with no extraskeletal manifestations. MDWH is caused by We diagnosed severe agranulocytosis in a subject with We collected clinical and laboratory data for a cohort of 80 patients with In our cohort, we identified 10 patients with skeletal but no extraskeletal features during preschool age. Eight of these patients developed malignancy or clinically significant immunodeficiency during follow-up. Two of them died during chemotherapy for malignancy. At the time of the first extraskeletal manifestation, patients were school aged, 20, 43 and 50 years old. Laboratory signs of immunodeficiency (impaired lymphocyte proliferative responses) were demonstrated in four patients before the onset of symptoms. The patient outside this cohort, who had MDWH can present with severe late-onset extraskeletal manifestations and thus should be reclassified and managed as CHH.

Sections du résumé

BACKGROUND
Metaphyseal dysplasia without hypotrichosis (MDWH) is a rare form of chondrodysplasia with no extraskeletal manifestations. MDWH is caused by
OBJECTIVE
We diagnosed severe agranulocytosis in a subject with
METHODS
We collected clinical and laboratory data for a cohort of 80 patients with
RESULTS
In our cohort, we identified 10 patients with skeletal but no extraskeletal features during preschool age. Eight of these patients developed malignancy or clinically significant immunodeficiency during follow-up. Two of them died during chemotherapy for malignancy. At the time of the first extraskeletal manifestation, patients were school aged, 20, 43 and 50 years old. Laboratory signs of immunodeficiency (impaired lymphocyte proliferative responses) were demonstrated in four patients before the onset of symptoms. The patient outside this cohort, who had
CONCLUSIONS
MDWH can present with severe late-onset extraskeletal manifestations and thus should be reclassified and managed as CHH.

Identifiants

pubmed: 31413121
pii: jmedgenet-2019-106131
doi: 10.1136/jmedgenet-2019-106131
pmc: PMC6929920
doi:

Substances chimiques

RMRP non-coding RNA, human 0
RNA, Long Noncoding 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

18-22

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: UW-K declares consultancy to Pfizer, Amgen, Novartis and Sanofi. OM declares consultancy to Kyowa Kirin, Alexion and Sandoz.

Références

Am J Med Genet A. 2006 Oct 1;140(19):2121-30
pubmed: 16838329
Am J Hum Genet. 2005 Nov;77(5):795-806
pubmed: 16252239
Eur J Pediatr. 1993 Mar;152(3):211-7
pubmed: 8444246
Am J Med Genet. 2001 Apr 1;99(4):289-93
pubmed: 11251995
Hum Mol Genet. 2005 Dec 1;14(23):3723-40
pubmed: 16254002
J Med Genet. 1990 Nov;27(11):693-6
pubmed: 2277385
PLoS Genet. 2011 Mar;7(3):e1002027
pubmed: 21455487
Clin Genet. 2017 Aug;92(2):204-207
pubmed: 28094436
Am J Med Genet A. 2008 Sep 15;146A(18):2370-5
pubmed: 18698627
J Med Genet. 2001 Apr;38(4):262-5
pubmed: 11370632
Duodecim. 1989;105(18):1540-6
pubmed: 2680445
Eur J Hum Genet. 2002 Jul;10(7):439-47
pubmed: 12107819
Eur J Pediatr. 1998 Oct;157(10):816-20
pubmed: 9809821
J Allergy Clin Immunol. 2008 Dec;122(6):1178-84
pubmed: 18804272
Am J Hum Genet. 2007 Sep;81(3):519-29
pubmed: 17701897
Pediatr Radiol. 1992;22(6):434-9
pubmed: 1437368
J Med Genet. 2003 Oct;40(10):741-6
pubmed: 14569119
J Allergy Clin Immunol. 2017 Aug;140(2):612-614.e5
pubmed: 28284971
Curr Opin Allergy Clin Immunol. 2008 Dec;8(6):534-9
pubmed: 18978468
Clin Genet. 2002 Feb;61(2):146-51
pubmed: 11940090

Auteurs

Svetlana Vakkilainen (S)

New Children's Hospital, Pediatric Research Center, University of Helsinki and HUS Helsinki University Hospital, Helsinki, Finland svetlana.vakkilainen@hus.fi.
Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.

Alice Costantini (A)

Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.
Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden.

Mervi Taskinen (M)

New Children's Hospital, Pediatric Research Center, University of Helsinki and HUS Helsinki University Hospital, Helsinki, Finland.

Ulla Wartiovaara-Kautto (U)

Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland.
Applied Tumor Genomics / Research Programs Unit, University of Helsinki, Helsinki, Finland.

Outi Mäkitie (O)

New Children's Hospital, Pediatric Research Center and Institute of Genetics, University of Helsinki and HUS Helsinki University Hospital and Folkhälsan Research Center, Helsinki, Finland.
Department of Molecular Medicine and Surgery and Center for Molecular Medicine and Department of Clinical Genetics, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH